WO2021081347A1
|
|
Duoplasmatron ion source with a partially ferromagnetic anode
|
US2021115456A1
|
|
Expression systems for cell-to-cell gene transfer in plants and methods of use thereof
|
WO2021072264A1
|
|
Oncolytic viruses that express multi-specific immune cell engagers
|
WO2021072273A1
|
|
Oncolytic virus comprising immunomodulatory transgenes and uses thereof
|
US2021100927A1
|
|
Bioactive polymeric dressing for accelerated wound closure
|
WO2021067550A1
|
|
Methods and compositions for identifying neoantigens for use in treating and preventing cancer
|
US2021104687A1
|
|
Green and red organic light-emitting diodes employing excimer emitters
|
WO2021062358A1
|
|
Objective assessment of patient response for calibration of therapeutic interventions
|
WO2021062370A1
|
|
Tracking articulatory and prosodic development in children
|
WO2021050812A1
|
|
Metabolic reprogramming of immune cells for the treatment or prevention of diseases and disorders
|
US2021089579A1
|
|
Method and apparatus for collecting, detecting and visualizing fake news
|
US2021061864A1
|
|
New oncolytic virus platform to treat cancers with myxoma virus
|
US2021060483A1
|
|
Device and method for co2 capture through circumscribed hollow membranes
|
WO2021046048A1
|
|
Methods and compositions for improving oncolytic virus infection for nonpermissive cancers
|
WO2021071604A2
|
|
Universal ground-based reduced gravity system
|
WO2021041696A1
|
|
Nerve repair using laser sealing
|
WO2021041471A1
|
|
Systems and methods for controlling shape and position of a ferrofluid droplet
|
US2021048428A1
|
|
Biomarkers for detection and treatment assessment of infectious diseases and disorders
|
WO2021030491A1
|
|
Perovskite/silicon tandem photovoltaic device
|
WO2021030433A1
|
|
Genetically engineered human fetal liver niche as platform for biomanufacturing of hematopoietic stem cells
|